Claim of superiority of SGA in the treatment of aggressiveness in schizophrenia is not supported by data

Psychopharmacology (Berl). 2016 Jun;233(12):2419-20. doi: 10.1007/s00213-016-4302-1. Epub 2016 Apr 28.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aggression
  • Antipsychotic Agents / therapeutic use*
  • Humans
  • Schizophrenia / drug therapy*

Substances

  • Antipsychotic Agents